Stockscreener 앱 받기
81.80
0.97%
-0.80
시간 외 거래:
81.80
Medtronic Plc 주식(MDT)의 최신 뉴스
Medtronic continues to close gap in diabetes tech - BioWorld MedTech
Medtronic gets FDA approval to use Simplera Sync glucose sensor with insulin pumps - MedTech Dive
Aortic Repair Devices Market Is Booming Worldwide 2025-2032 | Medtronic PLC,Cook Medical,Terumo Corporation - openPR.com
Medtronic nets FDA approval to pair Simplera Sync CGM with MiniMed 780G - Fierce Biotech
Medtronic: One Of The Best Times To Buy (NYSE:MDT) - Seeking Alpha
Medtronic wins FDA nod for new Simplera Sync CGM with MiniMed 780G - MassDevice
FDA approves Medtronic’s Simplera Sync sensor for MiniMed system - Medical Device Network
New Simplera Sync™ sensor for the MiniMed™ 780G System now FDA approved - Medtronic
FDA Approves Revolutionary Diabetes Sensor: Medtronic's New Tech Eliminates Fingersticks, Simplifies Management - Stock Titan
Medtronic (MDT) Stock Dips While Market Gains: Key Facts - Nasdaq
Medtronic (MDT) Faces Tariff Risks Amid Global Trade Changes - GuruFocus
Barclays Flags Medtronic, J&J as Most at Risk from Looming Pharma Tariffs - Yahoo Finance
Medtronic plc (MDT): A Bull Case Theory - Insider Monkey
Spinal Column Market Deep Research Report with Forecast by 2032 | - openPR.com
Tariffs top of mind for medtech firms this earnings season - MedTech Dive
Medtronic: Rock 'n' Roll Dad's New Music Inspired by Son's Diagnosis - Yahoo Finance
Is Now An Opportune Moment To Examine Medtronic plc (NYSE:MDT)? - simplywall.st
Medtronic (MDT) Gains But Lags Market: What You Should Know - Yahoo Finance
Truist Trims Price Target on Medtronic to $90 From $93, Keeps Hold Rating - marketscreener.com
Baird Adjusts Price Target on Medtronic to $94 From $91, Maintains Neutral Rating - MarketScreener
Intramedullary Nail Market size to worth USD 1,537 Million by 2032, says Coherent Market Insights - GlobeNewswire Inc.
Medtronic Becomes Oversold - Nasdaq
Medtronic's MiniMed 780G Leads in Time in Target Range for Type 1 Diabetes - Medical Device and Diagnostic industry
Citigroup Adjusts Medtronic Price Target to $103 From $107, Maintains Buy Rating - MarketScreener
Looking Into Medtronic's Recent Short Interest - Benzinga
Medtronic PLC (MDT) Shares Gap Down to $84.31 on Apr 4 - GuruFocus
Piper Sandler maintains Medtronic stock neutral with $90 target By Investing.com - Investing.com UK
Medtronic (MDT) Stock Moves -1.09%: What You Should Know - Nasdaq
May 23rd Options Now Available For Medtronic (MDT) - Nasdaq
Boston Scientific’s Farapulse matches Medtronic cryoablation in trial - MedTech Dive
Medtronic (MDT) Advances But Underperforms Market: Key Facts - Yahoo Finance
Former Medtronic CEO Criticizes RFK Jr.'s HHS Leadership - Medical Device and Diagnostic industry
Medtronic, Recor commence hostilities over RDN patents - BioWorld MedTech
3 takeaways from ACC 2025 - MedTech Dive
Evercore ISI Adjusts Medtronic Price Target to $105 From $104, Maintains Outperform Rating - MarketScreener
Boston Scientific’s Farapulse Triumphs Over Medtronic’s Artic Front in Atrial Fibrillation Trial - Medical Device and Diagnostic industry
The Zacks Analyst Blog Highlights Mastercard, Medtronic, HCA Healthcare and United Homes - Nasdaq
Medtronic plc (NYSE:MDT) Stake Boosted by Geode Capital Management LLC - MarketBeat
Medtronic Breaks Out Strong TAVR Data at ACC - Medical Device and Diagnostic industry
Top Stock Reports for Mastercard, Medtronic & HCA Healthcare - MSN
Medtronic (NYSE:MDT) TAVR System Shows Strong Five-Year Performance Despite 3% Price Dip - Yahoo
Stifel maintains Hold on Medtronic stock, sets $87 target By Investing.com - Investing.com UK
Medtronic Aortic Valve Replacement Device Shows Improvements Over Surgery in Heart Patients - MarketScreener
Medtronic plc (NYSE:MDT) Shares Sold by Meeder Asset Management Inc. - MarketBeat
Medtronic plc (MDT): Among the Best Dividend Aristocrat Stocks with Over 3% Yield - Insider Monkey
Medtronic Evolut™ TAVR system shows durable clinical outcomes and outstanding valve performance at five years in low-risk aortic stenosis patients - Medtronic
Prediction: Buying Medtronic Today Will Set You Up for Life - The Motley Fool
Prestige Wealth Management Group LLC Has $344,000 Stock Position in Medtronic plc (NYSE:MDT) - MarketBeat
Fed. Circ. Revives Recor's PTAB Challenge To Medtronic IP - Law360
Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Medtronic shares trade in green after seven straight days of losses - Seeking Alpha
Otsuka Gets Another Shot Challenging Medtronic Patent's Validity - Bloomberg Law News
1.99%
자본화:
|
볼륨(24시간):